Related references
Note: Only part of the references are listed.Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials
Eva Heilmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Initial Immune Response in Escherichia coli, Staphylococcus aureus, and Candida albicans Bacteremia
Vaios Spyropoulos et al.
INFLAMMATION (2020)
Antimicrobial-associated harm in critical care: a narrative review
Nishkantha Arulkumaran et al.
INTENSIVE CARE MEDICINE (2020)
Pharmacodynamics of immune response biomarkers of interest for evaluation of treatment effects in bacterial infections
Anders Thorsted et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
An Update on Sepsis Biomarkers
Mi-Hee Kim et al.
INFECTION AND CHEMOTHERAPY (2020)
Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study
C. S. Scheer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
The DILI-sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation
Paul B. Watkins
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Challenge model of TNFα turnover at varying LPS and drug provocations
Felix Held et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2019)
A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and interleukin-6
Anders Thorsted et al.
PLOS ONE (2019)
Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy
Soichiro Tajima et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-Analysis
Irena Iankova et al.
CRITICAL CARE MEDICINE (2018)
Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers
T. W. Felton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
Philipp Schuetz et al.
LANCET INFECTIOUS DISEASES (2018)
Exploring the Use of C-Reactive Protein to Estimate the Pharmacodynamics of Vancomycin
Timothy M. Rawson et al.
THERAPEUTIC DRUG MONITORING (2018)
Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction
Svenja Hinrichs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii Pneumonia
John K. Diep et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial
Gunnar Elke et al.
CRITICAL CARE (2018)
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies
James W. Dear et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients
Christian Radke et al.
CLINICAL PHARMACOKINETICS (2017)
Evidence of NI-0101 Pharmacological Activity, an Anti-TLR4 Antibody, in a Randomized Phase I Dose Escalation Study in Healthy Volunteers Receiving LPS
E. Monnet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial
Pietro Caironi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Predictive score of haematological toxicity in patients treated with linezolid
J. Gonzalez-Del Castillo et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
T. Tangden et al.
INTENSIVE CARE MEDICINE (2017)
Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study
Pedro Povoa et al.
JOURNAL OF CRITICAL CARE (2017)
Characterization of a model of systemic inflammation in humans in vivo elicited by continuous infusion of endotoxin
D. Kiers et al.
SCIENTIFIC REPORTS (2017)
The antibiotic course has had its day
Martin J. Llewelyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
The antibiotic course has had its day
Martin J. Llewelyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock
Juan-Jesus Rios-Toro et al.
PLOS ONE (2017)
Sepsis and Immunosenescence in the Elderly Patient: A Review
Silvia Martin et al.
FRONTIERS IN MEDICINE (2017)
Evaluating the value of dynamic procalcitonin and presepsin measurements for patients with severe sepsis
Han Yu et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2017)
Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children
Nienke J. Vet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy
V. Ramos-Martin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
Evelien de Jong et al.
LANCET INFECTIOUS DISEASES (2016)
Microdialysis as a way to measure antibiotics concentration in tissues
Sandrine Marchand et al.
PHARMACOLOGICAL RESEARCH (2016)
Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections
Silvia Angeletti et al.
APMIS (2015)
Presepsin (sCD14-ST), an innate immune response marker in sepsis
Camille Chenevier-Gobeaux et al.
CLINICA CHIMICA ACTA (2015)
Translational research and biomarkers in neonatal sepsis
Joris R. Delanghe et al.
CLINICA CHIMICA ACTA (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial
Serge Masson et al.
INTENSIVE CARE MEDICINE (2015)
Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin
J. G. C. van Hasselt et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Procalcitonin Algorithm in Critically Ill Adults with Undifferentiated Infection or Suspected Sepsis A Randomized Controlled Trial
Yahya Shehabi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
Jan J. De Waele et al.
INTENSIVE CARE MEDICINE (2014)
Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients
Evelien Assink-de Jong et al.
BMC INFECTIOUS DISEASES (2013)
The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models
Sirus Palsson et al.
BMC SYSTEMS BIOLOGY (2013)
Population pharmacokinetic-pharmacodynamic analysis for eribulin mesilate-associated neutropenia
J. G. Coen van Hasselt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
The current status of biomarkers for predicting toxicity
Sarah Campion et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Procalcitonin Guidance to Reduce Antibiotic Treatment of Lower Respiratory Tract Infection in Children and Adolescents (ProPAED): A Randomized Controlled Trial
Gurli Baer et al.
PLOS ONE (2013)
The developing human preterm neonatal immune system: A case for more research in this area
Ashish Arunkumar Sharma et al.
CLINICAL IMMUNOLOGY (2012)
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Philipp Schuetz et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Disease-Drug-Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis
C. Schmitt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
Pedro Povoa et al.
CRITICAL CARE (2011)
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
Roland Nau et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
C-reactive protein: A tool in the follow-up of nosocomial pneumonia
Marcelo Spegiorin Moreno et al.
JOURNAL OF INFECTION (2010)
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
Lila Bouadma et al.
LANCET (2010)
Next-generation biomarkers for detecting kidney toxicity
Joseph V. Bonventre et al.
NATURE BIOTECHNOLOGY (2010)
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function
Josef S. Ozer et al.
NATURE BIOTECHNOLOGY (2010)
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
Vishal S. Vaidya et al.
NATURE BIOTECHNOLOGY (2010)
Biomarkers for drug-induced liver injury
Qiang Shi et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
D. Stolz et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
The aging of the immune system
Daniela Weiskopf et al.
TRANSPLANT INTERNATIONAL (2009)
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
Marcel Hochreiter et al.
CRITICAL CARE (2009)
Use of procalcitonin to shorten antibiotic treatment duration in septic patients - A randomized trial
Vandack Nobre et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia
Thiago Lisboa et al.
CRITICAL CARE MEDICINE (2008)
Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer
Edward T. Morgan et al.
DRUG METABOLISM AND DISPOSITION (2008)
The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis
X. Schmit et al.
INFECTION (2008)
The influence of corticosteroids on the release of novel biomarkers in human endotoxemia
Martijn D. de Kruif et al.
INTENSIVE CARE MEDICINE (2008)
Advantage of serum type-I arginase and ornithine carbamoyltransferase in the evaluation of acute and chronic liver damage induced by thioacetamide in rats
Hiroshi Murayama et al.
CLINICA CHIMICA ACTA (2007)
Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis
EJ Giamarellos-Bourboulis et al.
INTENSIVE CARE MEDICINE (2006)
Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis
S Oda et al.
CYTOKINE (2005)
Liver enzyme alteration: a guide for clinicians
EG Giannini et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia
S Knapp et al.
JOURNAL OF IMMUNOLOGY (2004)
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents:: Distribution in tissue
M Müller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis
J Garnacho-Montero et al.
CRITICAL CARE MEDICINE (2003)
Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure
JA Carcillo et al.
INTENSIVE CARE MEDICINE (2003)
C-reactive protein is associated with renal function abnormalities in a non-diabetic population
EM Stuveling et al.
KIDNEY INTERNATIONAL (2003)
In vitro and in vivo calcitonin I gene expression in parenchymal cells: A novel product of human adipose tissue
P Linscheid et al.
ENDOCRINOLOGY (2003)
C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure
V Panichi et al.
NEPHRON (2002)
Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats
PJ O'Brien et al.
LABORATORY ANIMALS (2002)
Possible role of TNF on procalcitonin release in a baboon model of sepsis
H Redl et al.
SHOCK (2001)
Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock
C Joukhadar et al.
CRITICAL CARE MEDICINE (2001)
The natural elimination rate of procalcitonin in patients with normal and impaired renal function
M Meisner et al.
INTENSIVE CARE MEDICINE (2000)
Share Paper
